Thyroid Warning on GLP-1s Could Raise Overdiagnosis Risk

Top 5 Medications That Can Increase Blood Glucose Levels

Pharmacist-Led Management Model and Medication Adherence Among Patients With Chronic Heart Failure. A Randomized Clinical Trial

FDA Seeks to Remove Oral Phenylephrine From Decongestants

Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022

Boletín sobre Seguridad de Medicamentos de Uso Humano. Noviembre de 2024

Side Effects of GLP-1 Drugs: What Doctors Should Know

Infants Exposed to Minoxidil May Develop Hypertrichosis

Transdermal Beats Oral Estrogen for CVD Safety of Hormone Therapy

The Sexual Side Effects of Hormones and Other Drugs

Women Largely Unaware of Anti-Seizure Med Risks, More Education Needed

Lithium Use During Pregnancy in 14 Countries

Perspectives on Diversion of Medications From Safer Opioid Supply Programs

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy. A Systematic Review and Meta-Analysis

Prioritizing Research on Social Determinants of Health—“Yes, and…”

Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy. The VOICE Randomized Clinical Trial

Drug Overdose Deaths Among Medicaid Beneficiaries

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

Muscle-Building Supplements May Lead Young Men to Steroids

Some With Osteoporosis Should Not Take Drug Holidays

Health Impacts of Micro- and Nanoplastics

Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes

Aspirin for Secondary Prevention of Atherosclerosis—Evidence or Dogma?

Recommendations to Ensure Safety of AI in Real-World Clinical Care

Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

GLP-1 Labels Don’t Reflect Trial Exclusions

US Government Turns to Retail Pharmacies to Improve Representation in Clinical Trials

Efectos sexuales secundarios de las hormonas y otros fármacos

Risk for Ischemic Optic Neuropathy From Glucagon-Like Peptide 1 Receptor Agonists Too Rare to be Detected

Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits

Researcher Explores Using AI to Overcome Language Barriers With Patients

Ocular Side Effects Common in Real-World Study of Cancer Tx

Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database

Characteristics of the current situation of drug use in elderly patients with chronic diseases in Chongqing: A cross-sectional survey

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database

Artificial Intelligence and Machine Learning Models for Predicting Drug-Induced Kidney Injury in Small Molecules

Machine learning models for coagulation dysfunction risk in inpatients administered β-lactam antibiotics

Trends of drug-resistant tuberculosis and risk factors to poor treatment-outcome: a database analysis in Littoral region-Cameroon, 2013–2022

Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study

Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data

Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016

Minimizing the risk of ethylene glycol and diethylene glycol poisoning in medications: A regulatory and pharmacopoeial response

Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease

Transformative Role of Artificial Intelligence in the Pharmaceutical Sector

Real-World Pharmacovigilance Study Identifies Drugs Linked to Hepatitis B Virus Reactivation

DEEPSIDE A DEEP LEARNING FRAMEWORK FOR DRUG SIDE EFFECT PREDICTION

El inspector de la ANSM y presidente del Comité de Oficiales de PIC/S, Jacques Morènas, protagonista del cuarto diálogo del 25 aniversario de la AEMPS

UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver

The Future of Pharmacovigilance: Using Data Science to Predict and Prevent Adverse Drug Reactions

ADA Advises Against Using Compounded GLP-1 RA Medications

Health Care Actions for Reducing Plastic Use and Pollution

The Promise and Perils of Diversity Action Plans for Clinical Trials

Diversity Action Plans in Clinical Trials

Pharmacy Closures and Anticonvulsant Medication Prescription Fills

The applications and advances of artificial intelligence in drug regulation: A global perspective

Post-marketing regulatory actions in Portugal—A retrospective analysis between 2013 and 2023

Legal and scientific deficiencies of drug advertisements on German television

Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy

Pharmacovigilance insights into drug-induced cystitis: analysis of FDA data from 2004 to 2024

Online Pharmacies in India and 3 massive problems!

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline

The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: a 2-year experience report

Adverse events associated with oseltamivir and baloxavir marboxil in against influenza virus therapy: A pharmacovigilance study using the FAERS database

Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French pharmacovigilance database

Adverse Drug Reactions and Safety Profiles in Cardiovascular Drug Therapy: A Pharmacovigilance Analysis

A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

A systematic review of efficacy and safety of newer drugs approved from 2016 to 2023 for the treatment of complicated urinary tract infections

Possible Adverse Effects (AEs) of Semaglutide (Ozempic) Administration for the Latest Investigation

Pharmacovigilance analysis of drug-induced hypobrinogenemia using the FDA Adverse Event Reporting System

Assessment of the supply chain vulnerabilities for the first tranche of the Union list of critical medicines: Technical report

Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial

Gabapentinoids and Risk of Hip Fracture

Nurse Burnout and Patient Safety, Satisfaction, and Quality of Care. A Systematic Review and Meta-Analysis

Early Appropriate Antibiotic Use for CRE and MDR P. aeruginosa Infections: Epidemiology, Risk Factors, and Diagnostics

A critical pathway to reducing maternal, newborn and child mortality

As GLP-1 Use Surges, Clinicians Weigh Benefits and Risks

Dealing with adverse drug reactions in the context of polypharmacy using regression models

Systematic review and meta-analysis on effectiveness of strategies for enhancing adverse drug reaction reporting

Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other Countries

Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study

Global Risk of AKI and Tubulointerstitial Nephritis following Anticancer Drug Administration, 1967-2023: Long-Term Pharmacovigilance Analysis FR-PO038

Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity

Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. A Randomized Clinical Trial

Perspective Chapter: Application of Artificial Intelligence in Pharmacovigilance Practices

A real-world study of denosumab-related hypocalcaemia based on the US food and Drug Administration Adverse Event Reporting System database

Safety of the contrast enhancement agent sulfur hexafluoride in ultrasound: Analysis of the Federal Drug Administration Adverse Event Reporting System database

Safety Profile of Biological Drugs in Clinical Practice: A Retrospective Pharmacovigilance Study

Effectiveness of an intervention to improve pharmacovigilance among selected government hospitals in a district of Sri Lanka

What are the unintended patient safety consequences of healthcare technologies? A qualitative study among patients, carers and healthcare providers